Catalent Inc Business Finance Contracts & Agreements

38 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Registration Rights Agreement between Catalent, Inc. and Green Equity Investors VII, L.P. et al.
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
2024
Amendment No. 10 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Subsidiary Guarantors, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2023
Amendment No. 9 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Subsidiary Guarantors, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2023
Underwriting Agreement between Catalent, Inc. and RBC Capital Markets, LLC for Common Stock Offering (June 10, 2020)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2020
Catalent, Inc. Common Stock Underwriting Agreement with J.P. Morgan Securities LLC and UBS Securities LLC (February 2020)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2020
Registration Rights Agreement, dated as of May 17, 2019, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP Associates VII-A...
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Form of 2018 OIP Restricted Stock Unit Agreement for Non-U.S. Employees
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Form of 2018 OIP Restricted Stock Unit Agreement for U.S. Employees
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Equity Commitment and Investment Agreement between Catalent, Inc. and Green Equity Investors VII, L.P. and Green Equity Investors Side VII, L.P. dated April 14, 2019
Investment Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Catalent, Inc. Common Stock Underwriting Agreement with J.P. Morgan, Morgan Stanley, and RBC Capital Markets (July 24, 2018)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2018
Amendment No. 3 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
KS
2017
Underwriting Agreement between Catalent, Inc. and Morgan Stanley, J.P. Morgan, and RBC Capital Markets (September 26, 2017)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2017
Amendment No. 2 to Amended and Restated Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, and Morgan Stanley Senior Funding, Inc.
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2016
Indenture for 4.750% Senior Notes Due 2024 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Trustee Company Limited
Indenture Agreements
Catalent Inc
Pharmaceuticals
DE
2016
Catalent, Inc. Common Stock Underwriting Agreement with Goldman Sachs, Deutsche Bank, and Morgan Stanley (2016)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2016
Catalent, Inc. and Selling Stockholders Underwriting Agreement with Goldman, Sachs & Co. (June 6, 2016)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2016
Catalent, Inc. Common Stock Underwriting Agreement with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC (2015)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2015
Catalent, Inc. Common Stock Underwriting Agreement with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC (2015)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2015
Amendment No. 1 to Credit Agreement among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, and Lenders
Credit Agreements
Catalent Inc
Pharmaceuticals
NY
2014
Registration Rights Agreement by and among Catalent, Inc., Blackstone, Genstar Phoenix Holdings, LLC, Aisling Capital II, L.P., and Management Stockholders (August 5, 2014)
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
NY
2014
Registration Rights Agreement by and among Catalent, Inc. and Certain Stockholders (2014)
Registration Rights Agreements
Catalent Inc
Pharmaceuticals
NY
2014
Catalent, Inc. Underwriting Agreement with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC (2014)
Underwriting Agreements
Catalent Inc
Pharmaceuticals
2014
Catalent, Inc. 2018 Omnibus Incentive Plan Option Agreement for Non-U.S. Participants
Equity Distribution Agreements
Catalent Inc
Pharmaceuticals
NJ
2022
Description of Capital Stock and Related Agreements of Catalent, Inc.
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2022
Indenture Agreement for 3.500% Senior Notes Due 2030 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2021
Membership Interest Purchase Agreement among Catalent Pharma Solutions, Inc., Bettera Holdings, LLC, and Members
Purchase Agreements
Catalent Inc
Pharmaceuticals
DE
2021
Indenture for 3.125% Senior Notes Due 2029 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2021
Indenture for 2.375% Senior Notes Due 2028 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Trustee Company Limited
Indenture Agreements
Catalent Inc
Pharmaceuticals
DE
2020
Stock Purchase Agreement among Orgenesis Inc., GPP-II Masthercell, LLC, Masthercell Global Inc., and Catalent Pharma Solutions, Inc. dated February 2, 2020
Purchase Agreements
Catalent Inc
Pharmaceuticals
DE
2020
Catalent, Inc. Description of Capital Stock as of June 30, 2019
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2019
Indenture Agreement for 5.00% Senior Notes Due 2027 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2019
Form of 2018 OIP Performance Share Unit Agreement for Non-U.S. Employees (three-year performance period)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Form of 2018 OIP Performance Share Unit Agreement for U.S. Employees (three-year performance period)
Stock Agreements
Catalent Inc
Pharmaceuticals
NJ
2019
Catalent, Inc. 2019 Employee Stock Purchase Plan
Stock Agreements
Catalent Inc
Pharmaceuticals
DE
2018
Indenture for 4.875% Senior Notes Due 2026 among Catalent Pharma Solutions, Inc., Guarantors, and Deutsche Bank Trust Company Americas
Indenture Agreements
Catalent Inc
Pharmaceuticals
NY
2017
Interest Purchase Agreement among Catalent Pharma Solutions, Inc., Cook Pharmica LLC, and Cook Group Incorporated (September 18, 2017)
Purchase Agreements
Catalent Inc
Pharmaceuticals
DE
2017
Stockholders Agreement between Catalent, Inc. and Blackstone Healthcare Partners L.L.C. dated August 5, 2014
Shareholders Agreements
Catalent Inc
Pharmaceuticals
DE
2014
Stockholders Agreement among Catalent, Inc., Blackstone Healthcare Partners L.L.C., and Phoenix Charter LLC (2014)
Shareholders Agreements
Catalent Inc
Pharmaceuticals
DE
2014